more_reports

Adaptimmune Therapeutics Plc

ADAP:NASDAQ

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.

streetwise book logo Streetwise Company Fact Sheet

2025/7/25 3:11:06

(ADAP:NASDAQ)